ARCHIVES

Regulatory Approvals: FDA expanded the approved use of Cyramza to include metastatic NSCLC

This article is from The Cancer Letter archive.

Vol. 40 No. 47 | December 19, 2014

Download PDF Visit The Full Archive

Related Articles

Urocidin May Provide Alternative To Cystectomy in BCG Cancers

May 27, 2011

Cancer Advocacy: Jay Hedlund Resigns As NPCC President

May 14, 1999

Clinical Research: Enough Studies Done, Time For Solutions, CSR Report Says

February 20, 1998

Public Health Service: Blumenthal Declines White House Job

November 14, 1997

Phase III Trial: Panobinostat Increases PFS by Four Months

September 26, 2014

Professional Societies: Organizations Form Alliance To Call For Quality Cancer Care

October 9, 1998